ECSP951486A - PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC COLOR - Google Patents
PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC COLORInfo
- Publication number
- ECSP951486A ECSP951486A ECSP951486A ECSP951486A EC SP951486 A ECSP951486 A EC SP951486A EC SP951486 A ECSP951486 A EC SP951486A EC SP951486 A ECSP951486 A EC SP951486A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- compositions
- gastric
- color
- pharmaceutical methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002496 gastric effect Effects 0.000 title 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 2
- 206010000087 Abdominal pain upper Diseases 0.000 abstract 1
- JIFPTBLGXRKRAO-UHFFFAOYSA-K aluminum;magnesium;hydroxide;sulfate Chemical compound [OH-].[Mg+2].[Al+3].[O-]S([O-])(=O)=O JIFPTBLGXRKRAO-UHFFFAOYSA-K 0.000 abstract 1
- 229940069428 antacid Drugs 0.000 abstract 1
- 239000003159 antacid agent Substances 0.000 abstract 1
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract 1
- 230000001667 episodic effect Effects 0.000 abstract 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 abstract 1
- 229960004018 magaldrate Drugs 0.000 abstract 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 abstract 1
- 229960004872 nizatidine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a las composiciones farmacéuticas y método de tratamiento para proporcionar alivio instantáneo y prolongado del dolor o síntomas asociados con acidez episódica o dolor gástrico en humanos, conteniendo h2 - receptor antagonista y antiácidos, mas particularmente composiciones y métodos de tratamiento que contengan (1) nizatidino y (2) carbonato de calcio o magaldrato.The present invention relates to pharmaceutical compositions and method of treatment for providing instantaneous and prolonged relief of pain or symptoms associated with episodic acidity or gastric pain in humans, containing h2-receptor antagonist and antacids, more particularly compositions and methods of treatment containing (1) nizatidine and (2) calcium carbonate or magaldrate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951486 ECSP951486A (en) | 1995-07-20 | 1995-07-20 | PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC COLOR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP951486 ECSP951486A (en) | 1995-07-20 | 1995-07-20 | PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC COLOR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP951486A true ECSP951486A (en) | 1996-12-13 |
Family
ID=42042131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP951486 ECSP951486A (en) | 1995-07-20 | 1995-07-20 | PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF GASTRIC COLOR |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP951486A (en) |
-
1995
- 1995-07-20 EC ECSP951486 patent/ECSP951486A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2057412T3 (en) | METHOD TO INCREASE SALIVATION IN PATIENTS WITH XEROSTOMY. | |
| ES2058815T3 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DEVELOPMENTS. | |
| EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
| DE69113029D1 (en) | USE OF VITAMIN-D ANALOGA TO TREAT ACNE. | |
| HU9501053D0 (en) | Ranitidine chewable tablets | |
| ES2058346T3 (en) | PIPERIDINYLIC COMPOUNDS 1,4-DISSTITUTED. | |
| ES2188582T3 (en) | THE USE OF RANITIDINE-BISMUTE CITRATE IN COMBINATION WITH CLARITROMYCIN OR CLARITROMYCIN AND TETRACICLINE IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT GASTROINTESTINAL DISORDERS. | |
| DK0578768T3 (en) | Deductible pharmaceutical compositions for the treatment of upper gastrointestinal disorders | |
| NO943846D0 (en) | Angiotensin II antagonists for disorders associated with impaired nerve conduction velocity, especially diabetic neuropathy | |
| ATE184788T1 (en) | COMPOSITIONS CONTAINING IDEBENONE FOR THE TREATMENT OF ALZHEIMER'S M | |
| ES8700232A1 (en) | Vitamin D3 derivatives. | |
| DE69111974D1 (en) | Use of lithium for the treatment or prophylaxis of Molluscum contagiusum. | |
| GR3007508T3 (en) | ||
| GR3007995T3 (en) | ||
| ES2150418T3 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING CALCITONIN. | |
| GB2231794A (en) | Method for treating and preventing loss of bone mass | |
| ATE137967T1 (en) | USE OF KETOROLAC TO TREAT PERIODONTITIS | |
| ATE207357T1 (en) | USE OF COTININE TO RELIEF TOBACCO WITHDRAWAL SYNDROME | |
| ES2090121T3 (en) | MODULATION OF THE RESPONSE OF ADENYLATE CICLASA. | |
| DK277387A (en) | THERAPEUTIC TOPICAL COMPOSITION AGAINST A HYPERPROLIFIING EPITHAL DISEASE | |
| RO96600A2 (en) | COMPOSED TAMPONATED MEDICAMENT FOR CALCIUM TREATMENT | |
| ATE157250T1 (en) | BISMUTH SUBSALICYLATE IN THE FORM OF A UNIT DOSE | |
| SE8700157L (en) | WAY TO PREVENT Mercury Poisoning Caused by Dissolution of Mercury Silver from AMALGAM SEALS AND COMPOSITION THEREOF | |
| IT1265086B1 (en) | Association of macrolids and antacids in anti-ulcer pharmaceutical compositions having an antibacterial action | |
| DE69012630D1 (en) | Anti-rats. |